Submit Deal

LONGBOARD PHARMACEUTICALS

HQ - La Jolla

Summary

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 1.91 B

Avg. Deal Size£ 1.91 B

Market Context

Senior Management

Kevin R. Lind
President and CEO
Brandi Roberts
CFO

Sort

14 Oct 2024|United States|Biotechnology

Target: LONGBOARD PHARMACEUTICALS

Bidder: LUNDBECK AS

8 Service Providers

4 Target | 4 Bidder

35 Dealmakers

23 Target | 12 Bidder

£ 1.91 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy